+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By Treatment Type (Immune prophylaxis, Other), By Distribution Channel (Clinics, Other) -Estimation & Forecast - Product Thumbnail Image

Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By Treatment Type (Immune prophylaxis, Other), By Distribution Channel (Clinics, Other) -Estimation & Forecast

  • Report
  • June 2021
  • 675 Pages
  • Global
From
Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030 - Product Thumbnail Image

Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030

  • Report
  • March 2020
  • 306 Pages
  • Global
From
Human Papillomavirus (HPV) Vaccines - Global Strategic Business Report - Product Thumbnail Image

Human Papillomavirus (HPV) Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 279 Pages
  • Global
From
Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report by Type (Viral, Bacterial, Combination), Infection (COVID-19, Influenza), Age Group, Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report by Type (Viral, Bacterial, Combination), Infection (COVID-19, Influenza), Age Group, Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • May 2025
  • 100 Pages
  • Global
From
Avian Influenza Vaccine - Global Strategic Business Report - Product Thumbnail Image

Avian Influenza Vaccine - Global Strategic Business Report

  • Report
  • September 2025
  • 286 Pages
  • Global
From
Respiratory Disease Vaccine Market Report 2025 - Product Thumbnail Image

Respiratory Disease Vaccine Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2025 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Respiratory Syncytial Virus (RSV)- Pipeline Insight, 2025 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
COVID-19 Current Therapy Market Report 2025 - Product Thumbnail Image

COVID-19 Current Therapy Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Vaccine Contract Manufacturing Market: Industry Trends and Global Forecasts to 2035: Type of Expression System Used (Mammalian, Microbial and Others), Company Size and Geographical Region - Product Thumbnail Image

Vaccine Contract Manufacturing Market: Industry Trends and Global Forecasts to 2035: Type of Expression System Used (Mammalian, Microbial and Others), Company Size and Geographical Region

  • Report
  • August 2024
  • 381 Pages
  • Global
From
Anti-infective Vaccines Market Report 2023-2033 - Product Thumbnail Image

Anti-infective Vaccines Market Report 2023-2033

  • Report
  • September 2023
  • 303 Pages
  • Global
From
Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine, Type - Global Forecast to 2029 - Product Thumbnail Image

Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine, Type - Global Forecast to 2029

  • Report
  • December 2024
  • 389 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 307 Pages
  • Global
From
Vaccines Market by Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, HPV, Herpes Zoster, MMR, Rotavirus, RSV), Route of Administration - Forecast to 2029 - Product Thumbnail Image

Vaccines Market by Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, HPV, Herpes Zoster, MMR, Rotavirus, RSV), Route of Administration - Forecast to 2029

  • Report
  • April 2024
  • 402 Pages
  • Global
From
United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2033 - Product Thumbnail Image

United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2033

  • Report
  • January 2025
  • 230 Pages
  • United States
From
Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032) - Product Thumbnail Image

Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)

  • Report
  • January 2025
  • 388 Pages
  • Global
From
Global Influenza Vaccines Market and Forecasts 2024-2032 - Product Thumbnail Image

Global Influenza Vaccines Market and Forecasts 2024-2032

  • Report
  • January 2024
  • 310 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2025

  • Clinical Trials
  • June 2025
  • 281 Pages
  • Global
From
Vaccine Sales Market Report 2023-2033 - Product Thumbnail Image

Vaccine Sales Market Report 2023-2033

  • Report
  • June 2023
  • 364 Pages
  • Global
From
Loading Indicator